Model
Edge
Five Prime Therapeutics, Inc.
0001329049
Filing Type
4
Filing Date
3/3/2019
Updated
3/4/19, 11:21 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership